News

MG2 technology in the fight against COVID-19: a G140 will produce the Molnupiravir

Read the ITALIAN version

Alongside vaccines, the fight against the Covid-19 pandemic also involves new drugs to treat the symptoms.

In recent weeks, two medicines have been given the green light by the authorities in the treatment of patients affected by Coronavirus. And one of these, the Molnupiravir, will have an Italian matrix: a G140, indeed, will produce the capsule version of the anti COVID-19 medication in the factory of Stellapharm, a leading Vietnamese pharmaceutical company which produces both prescription drugs and non-prescription especially in cardiovascular diseases, antiviral drugs, anti-diabetics drugs.

Stellapharm is currently one of three manufacturers in Vietnam which mainly deliver Molnupiravir for the local market.

It is also the only pharmaceutical manufacturer in Vietnam, among 27 generic manufacturers, which has recently signed agreement with MPP – Medicines Patent Pool – to both produce and supply the low-cost version of COVID-19 antiviral medication in 105 low-middle-income countries.

The G140 is a continuous-motion capsule filling machine for medium and large productions that allows to dose pharmaceutical products such as powder and pellets.
Thanks to a highly sophisticated technology made at MG2, G140 ensures a high level of accuracy in all production phases, with a maximum speed up to 140.000 capsules/hour.

STELLA Molnupiravir 400 mg capsules produced with G140 capsule filler

It is acknowledged that this is the second G140 machine at Stellapharm, the previous one was bought in 2019, totally meeting high production and efficiency expectations.The latest capsule filling machine has been delivered to prepare for mass production at Stellapharm Binh Duong site, following the authorization approval for Molnupiravir STELLA 400 mg by Drug Administration of Vietnam, right after the news of authorization of the drug Molnupiravir in the United States by US FDA (Food & Drug Administration).

The relationship with Stellapharm has been consolidated, not only because of the high technological standard of the G140, but also thanks to the MG2 after-sales support, which can count on the local partner Rieckermann with its technical staff trained on the machines of the Italian company.

G140 capsule filling machine in
Stellapharm clean room

Stellapharm drugs are used by millions of patients in more than 50 countries around the world and its manufacturing facilities have been audited and approved by stringent authority like EMA, PMDA, Taiwan GMP, local WHO and others.

Rieckermann Vietnam
MG2 official Partner for VIETNAM

Ho Chi Minh City Office
16th floor, Tower B, Viettel Trade Center
285 Cach Mang Thang Tam Street
Ward 12, District 10
Ho Chi Minh City, Vietnam

Phone: +84 28 3839 9899
Email: hochiminhcity@rieckermann.com

Hanoi Office
7th Floor, VG-Building
235 Alley, Nguyen Trai Street
Thanh Xuan District
Hanoi, Vietnam

Phone: +84 24 3823 8661
Email: hanoi@rieckermann.com


MG2. Keeping ahead for you

MG2 News MG2 technology in the fight against COVID-19: a G140 will produce the Molnupiravir